Johns Hopkins ABX Guide
Didanosine
INDICATIONS
FDA
FDA
- Treatment of HIV infection in combination with other antiretrovirals.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: July 16, 2023
Citation
Auwaerter, Paul G, and Janessa Smith. "Didanosine." Johns Hopkins ABX Guide, The Johns Hopkins University, 2023. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540170/all/Didanosine.
Auwaerter PG, Smith J. Didanosine. Johns Hopkins ABX Guide. The Johns Hopkins University; 2023. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540170/all/Didanosine. Accessed December 4, 2024.
Auwaerter, P. G., & Smith, J. (2023). Didanosine. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540170/all/Didanosine
Auwaerter PG, Smith J. Didanosine [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2023. [cited 2024 December 04]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540170/all/Didanosine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Didanosine
ID - 540170
A1 - Auwaerter,Paul,M.D.
AU - Smith,Janessa,Pharm.D. BCPS
Y1 - 2023/07/16/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540170/all/Didanosine
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
